Latest Regulatory Approval News

Westgold Resources Limited has announced a 3 cent per share final dividend for the financial year ending June 2025, payable in October. The dividend is unfranked, reflecting the company’s current tax position.

Zoono Group Limited reported a 19.1% revenue increase to NZ$1.25 million for FY2025, alongside a significantly reduced net loss. The company is pivoting towards B2B markets, focusing on antimicrobial and shelf-life extension technologies, supported by a recent AUD 1.78 million capital raise.

Stellar Resources has reported a significant tin discovery at its Severn deposit, revealing a high-grade core that could expand and upgrade the Heemskirk Mineral Resource Estimate. The company is accelerating drilling and prefeasibility studies, signaling strong growth potential.

Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.

Dimerix Limited reported a 22% reduction in its FY2025 loss to $13.25 million, driven by strong licensing revenues and advancing its pivotal Phase 3 clinical trial for DMX-200. The company secured new global partnerships valued at up to AU$1.4 billion, bolstering its cash reserves and commercial prospects.

BetMakers Technology Group delivered a strong FY25 with a 5.6% half-on-half revenue growth and record profitability, while advancing its technology transformation and signing a strategic acquisition in Nevada.

Emyria Limited reports a reduced net loss of $3.14 million for FY2025, driven by strategic expansion in psychedelic-assisted mental health treatments and key partnerships including insurer Medibank. The company advances clinical services while continuing R&D on proprietary medicines.

Micro-X Limited reported a $13.9 million loss for FY2025 as it pivots towards medical imaging, securing a landmark supply agreement with a major US healthcare provider for its Rover Plus mobile X-ray system.

Diatreme Resources has agreed to sell its Clermont Gold Project to Moonlight Resources as part of Moonlight’s upcoming ASX IPO, securing a significant equity stake and board representation.

Moonlight Resources, partly owned by Lithium Plus Minerals, plans to acquire the Clermont Gold Project and pursue an ASX listing, aiming to become a focused gold and critical minerals explorer.

FOS Capital reported solid FY25 results, driven by organic growth and key acquisitions that expanded its market footprint and improved profitability. The company’s strategic moves position it well for continued consolidation in the fragmented lighting industry.

Zoono Group Limited has raised an additional A$992,000 through a shortfall placement, boosting its working capital to support global expansion of its shelf-life extension technology. The company also linked CEO share incentives to ambitious sales targets, signaling confidence in growth prospects.